secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K/A
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0000950170-24-015482
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Core Laboratories amends Q4 2023 results; net income cut by $4.3M on tax error
------------------------------------------------------------------------------

- Q4 2023 GAAP net income restated to $2.2M from $6.5M; diluted EPS revised to $0.05 from $0.14.
- FY 2023 GAAP net income restated to $36.7M from $40.9M; diluted EPS revised to $0.77 from $0.86.
- Understated income tax expense of $4.3M in Q4 due to reassessment of foreign tax credits after redomestication.
- Revenue, operating income, and cash from operations unchanged; ROIC revised from 13.4% to 12.0%.
- Management reaffirms Q1 2024 effective tax rate guidance of 20%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024015482/0000950170-24-015482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024015482/clb-20240131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-015482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer